ACOR Inflection Point !!

Discussion in 'Acorda Therapeutics' started by anonymous, May 28, 2019 at 9:10 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    We rank&file look forward to an upward trajectory of revenue in the coming months. With that of course the healthy uptick in share price of ACOR. Lets all recommit to excellence in performance ! The future is awesum !!!!!!!!! GO GO GO !!!!!!!!!!!!!!!!
     

  2. anonymous

    anonymous Guest

    Excellence starts by spelling correctly the word "awesome"

    Utterly disappointed at the lack of attention to details. Habib, Pay attention!

    MAGA
     
  3. anonymous

    anonymous Guest

    Now you are posing as the rank & file who you despise, Habib?

    I wouldn’t get too excited for an uptick anytime soon. The only way stock will rise after the quarterly meeting is if LRon announces he isn’t stepping aside and a new ceo with a reputation for making things happen is announced.

    Otherwise it’s the same ole crap and a slide to $4/share.
     
  4. anonymous

    anonymous Guest

    Wall Street pros have spoken. ACOR is over. Slide to $4 is imminent.
     
  5. anonymous

    anonymous Guest

    Many finance pros and even Mensa level savants see strong probability (note astrological analysis etc) and wealth opportunity in ACO R turnaround. We of the rank&file must keep our nose to the grindstone (old English saying) and focus on Inbrija sales explosion!!! So let's all take any negative thoughts with a large grain of skepticism!!!
     
  6. anonymous

    anonymous Guest

    yes that is so true. many of us rank and file are slacking off and must reset our efforts for the benefit of all.
     
  7. anonymous

    anonymous Guest

    You, of the rank and file “stop talking” and “start showing”. Keep your nose to grindstone and just stop posting , your embarrassing yourself and the company if you think lobbying on this site will move the needle, your managing in the minors, rookie...
     
  8. anonymous

    anonymous Guest

    That's right!!!

    We need the sales force executing executing and executing to perfection.

    Let's make Inbrija the #1 PD prescribed drug EVER
     
  9. anonymous

    anonymous Guest

    Sale reps are all behind the strategy
    Sir, yes, Sir!!!!!!

    ACOR will hit 20 soon
     
  10. anonymous

    anonymous Guest

    Yes ... 20 cents
     
  11. anonymous

    anonymous Guest

    Most reputable financial analysts see $17.50 to 28.00 target WITHIN 12 months This is FACT ! We in the rank & file must redouble our efforts to see this realized!
    Rest assured the Leadership believes this and that's why Acorda will NEVER be sold to a acquisition shark. They all have our back and ALL will be rewarded generously. BTW who else has Mensa level Leadership??

    So our job, as humble rank&file, is to set a stretch target to achieve record Inbrija sales. This is truly a ballbuster and the world is ours with inhaled LD !!!

    Lets GO GO GO !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
     
  12. anonymous

    anonymous Guest

    Who else has MENSA level Leadership?

    Easy

    The Government of Honduras and the City of Baltimore.

    Rats have IQs above 180
     
  13. anonymous

    anonymous Guest

    totally disgusting ..we have the world class team here and rank and filers should be tankful !
     
  14. anonymous

    anonymous Guest

    "tankful"

    Yes, ACOR tank'ed today over 1 %
    Your continuous lack of attention to details and misspellings were contributing factors.
     
  15. anonymous

    anonymous Guest

    Don’t be too hard on Habib.

    He has his hands full going through the retinue of pre approved posts to cover for tomorrow’s investor call. Couple that with selecting LRons costume for the event so it won’t miss his hair, and you can excuse a misspelling here or there.

    Good luck tomorrow little buddy.

    $1.3M in q1 for Inbrija
    35% over paid CEO
    Down 70%
    Paper pipeline
    Heavy debt load

    This is going to be entertaining. It’s like ACOR is the Baltimore of Pharma companies.
     
  16. anonymous

    anonymous Guest

    Good luck, your world will implode once your report the quarter. No amount or rallying or voodoo posts you write will matter. The street will speak and your stock price will retreat. Wonder what spin you bozo’s will craft once your stock gets slammed. Seems your time would have been better spent nurturing the launch than your nonsense babble on CP. you made your choice, get ready to digest your results.
     
  17. anonymous

    anonymous Guest

    You are a Nervus Nellie !! Rank&File are ready to accept the challenge and we know the holy grale is just over the horizon. Our Inbrija will set sales records for PD treatment and our Leadership will achieve accolades for the rebound as ACOR hit over $17 within 12 months. Fact is Wall Street predict this with near 100% accuracy.
     
  18. anonymous

    anonymous Guest

    Awesome ball busting success today Habib!

    The Wall Street pros have spoken and ACOR is officially a tax write off against other gains.

    New 52 week low achieved and further plummeting after hours.

    Enjoy $4 Friday!
     
  19. anonymous

    anonymous Guest

    Awesome ball busting success today on Habib’s Ballz by my Mother

    Habib had spoken and ACOR wins. He drained his ballz on my Mothers chin

    New 52 week low for my Mother.

    Enjoy $4 Blow Job Friday from Mom
     
  20. anonymous

    anonymous Guest

    ACOR's modest drop today was simply due to being caught up in the broad market meltdown due to the concern over further tariffs on Chinese goods The rebound and target of $17 to $28 is INTACT !!!!
    That said, This is a once in a generation time to buy low n sell high, if you have the resources !

    Reminder:

    Inbrija remains a proverbial ballbuster product !!

    Leadership is in place !

    Inbrija worldwide markets are in development !

    Lets GO GO GO !!!